Alexander Y. Tokman's Insider Trades & SAST Disclosures
Alexander Y. Tokman's most recent trade in ENDRA Life Sciences Inc was a trade of 600 Stock Options done . Disclosure was reported to the exchange on Jan. 2, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alexander Y. Tokman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
ENDRA Life Sciences Inc
|
Y. Alexander Tokman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 600 | 600 | - | - | Stock Options | |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 9,621 | 9,621 | - | - | Stock Options | |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 23 Nov 2022 | 10,000 | 162,857 | - | 0.2 | 1,700 | Common Stock |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Purchase of securities on an exchange or from another person at price $ 0.26 per share. | 22 Aug 2022 | 20,000 | 152,857 | - | 0.3 | 5,200 | Common Stock |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Purchase of securities on an exchange or from another person at price $ 0.20 per share. | 16 May 2022 | 100,000 | 132,857 | - | 0.2 | 19,630 | Common Stock |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 109,323 | 109,323 | - | - | Stock Options | |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 12,000 | 12,000 | - | - | Stock Options | |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 25,000 | 25,000 | - | - | Stock Options | |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 08 Jan 2021 | 10,000 | 32,857 | - | 0.9 | 9,000 | Common Stock |
|
ENDRA Life Sciences Inc
|
Alexander Y. Tokman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 12,000 | 12,000 | - | - | Stock Options |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges